COMMUNIQUÉS West-GlobeNewswire

MediciNova to Attend the Morgan Stanley Global Healthcare Conference in New York
05/09/2018
LA JOLLA, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
Veritas Appoints Lorne Mark Roseborough CEO of SunVault Energy to the Board of Directors
05/09/2018
VANCOUVER, British Columbia, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce the appointment of Lorne Mark [...]
CO2 GRO Inc. Engages a Senior Scientist in a Shares for Service Agreement
05/09/2018
TORONTO, Sept. 04, 2018 (GLOBE NEWSWIRE) -- CO2 GRO Inc. (“ CO2GRO ” or “ GROW ”) (TSX-V:GROW) announces that it has entered into an agreement with Dr. Luc Duchesne (“ Duchesne ”). Dr. Duchesne, PhD., Plant Biochemistry [...]
Agios Announces Chief Executive Officer Succession Plan
04/09/2018
- David Schenkein, M.D., Agios Long-Time Chief Executive Officer, to Become Executive Chairman, Effective February 1, 2019 - - Jacqualyn Fouse, Ph.D., to Succeed Dr. Schenkein as Chief Executive Officer - CAMBRIDGE, [...]
IMV Inc. Celebrates Grand Opening of New Facility in Dartmouth, Nova Scotia
04/09/2018
DARTMOUTH, Nova Scotia, Sept. 04, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, celebrated its grand opening today of its new facilities in Dartmouth, Nova [...]
Helix BioPharma Corp. collaborator ProMab Biotechnologies to present at the CAR-TCR Summit 2018 in Boston
04/09/2018
RICHMOND HILL, Ontario, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
BeiGene Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04/09/2018
CAMBRIDGE, Mass., and BEIJING, China, Sept. 04, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
National Research Corporation Declares Quarterly Dividend
04/09/2018
Lincoln, Nebraska, Sept. 04, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 (seventeen cents) per share [...]
Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
04/09/2018
EMERYVILLE, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that [...]
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
04/09/2018
BOSTON, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]
SpeakEasy Announces Non-Brokered Private Placement
04/09/2018
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 04, 2018 (GLOBE NEWSWIRE) -- SpeakEasy Cannabis Club Ltd. (CSE: EASY) ( [...]
TESARO Announces Expansion to Second Stage of JASPER Trial of ZEJULA® in Combination With TSR-042 in Non-Small Cell Lung Cancer
04/09/2018
All evaluable patients experienced tumor shrinkage Protocol defined response criteria achieved and trial expansion ongoing WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO), an oncology- [...]
Retrophin Announces Proposed Convertible Senior Notes Offering
04/09/2018
SAN DIEGO, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced its intention to offer, subject to market and other conditions, $200 million aggregate principal amount of convertible senior [...]
Aduro Biotech and Dana-Farber Cancer Institute Publish Data Highlighting Immunosuppressive Impact of APRIL in Multiple Myeloma in Leukemia
04/09/2018
BERKELEY, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced the publication of a peer reviewed paper in Leukemia authored by scientists from the Dana Farber Cancer Institute [...]
Rubius Therapeutics to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference
04/09/2018
CAMBRIDGE, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, announced today that [...]
Dova Pharmaceuticals Submits Supplemental New Drug Application for DOPTELET® (avatrombopag) for the Treatment of Chronic ITP
04/09/2018
DURHAM, N.C., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA), a specialty pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for diseases where [...]
Helius Medical Technologies to Participate in the 20th Annual Global Investment Conference Sponsored by Rodman & Renshaw and H.C. Wainwright & Co.
04/09/2018
NEWTOWN, Pa., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced it will be [...]
Sol-Gel Technologies Provides Program Update for TWIN for the Treatment of Acne Vulgaris
04/09/2018
Announces Positive End-of-Phase II Meeting with the FDA Receives Special Protocol Assessment (SPA) Agreement from FDA Company expects to commence the TWIN Phase III clinical trials in the fourth quarter of 2018 with top [...]
Dr. Yaron Werber, Chief Business and Financial Officer, to Return to Wall Street
04/09/2018
Dr. Werber will join Cowen and Company as Managing Director and Senior Biotechnology Analyst effective September 24, 2018 Ovid has initiated a search to select a new CFO NEW YORK, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Ovid [...]

Pages